Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 182,335 | 180,492 | 132,818 | 144,255 | 241,882 |
| Marketable Securities | 638,037 | 663,829 | 625,789 | 524,966 | 408,677 |
| Receivables | 94,475 | 91,102 | 90,608 | 88,952 | 89,568 |
| Inventories | 102,237 | 95,373 | 93,981 | 90,199 | 85,986 |
| TOTAL | $1,062,798 | $1,060,359 | $976,473 | $885,006 | $871,487 |
| Non-Current Assets | |||||
| PPE Net | 195,157 | 198,478 | 202,490 | 196,880 | 197,184 |
| Investments And Advances | 116,871 | 159,876 | 220,089 | 262,635 | 210,979 |
| Intangibles | 109,793 | 113,023 | 116,304 | 117,727 | 119,228 |
| Other Non-Current Assets | 211,925 | 171,900 | 158,037 | 130,629 | 131,156 |
| TOTAL | $633,746 | $643,277 | $696,920 | $707,871 | $658,547 |
| Total Assets | $1,696,544 | $1,703,636 | $1,673,393 | $1,592,877 | $1,530,034 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 35,070 | 34,797 | 35,346 | 32,066 | 27,621 |
| Accrued Expenses | 69,434 | 79,011 | 72,629 | 66,668 | 56,744 |
| Other current liabilities | 3,594 | 3,330 | 4,120 | 3,195 | 5,579 |
| TOTAL | $134,060 | $140,762 | $138,457 | $126,796 | $114,022 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 25,962 | 23,624 | 26,362 | 24,867 | 24,078 |
| Other Non-Current Liabilities | 22,008 | 25,943 | 30,829 | 32,344 | 30,617 |
| TOTAL | $22,697 | $26,678 | $31,610 | $33,143 | $31,449 |
| Total Liabilities | $156,757 | $167,440 | $170,067 | $159,939 | $145,471 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,091 | 45,461 | 45,564 | 45,516 | 45,497 |
| Common Shares | 452 | 456 | 455 | 455 | 455 |
| Retained earnings | 1,125,199 | 1,019,066 | 964,512 | 904,187 | 858,435 |
| Other shareholders' equity | -46,619 | -38,291 | -26,715 | -20,914 | -14,714 |
| TOTAL | $1,539,787 | $1,536,196 | $1,503,326 | $1,432,938 | $1,384,563 |
| Total Liabilities And Equity | $1,696,544 | $1,703,636 | $1,673,393 | $1,592,877 | $1,530,034 |